91P Phase I dose escalation of IMC-C103C, a CD3×MAGE-A4 T-cell receptor (TCR) bispecific protein D. Davar,R.F. Sweis, G. Blumenschein, R. Gutierrez,I. Melero,H.A. Chen,F. Thistlethwaite, K.N. Moore,N.H. Segal, E. Garralda,B. Wilky,H-T. Arkenau,T.R.J. Evans,M.L. Johnson, M. Dar,C. Holland, S. Marshall, S. Stanhope, P. Kirk,J.S. LopezAnnals of Oncology(2021)引用 4|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要